question if anyone is out there...Does Biomark even own their IP?
BIOMARK DIAGNOSTICS INC. Notes to the Condensed Consolidated Interim Financial Statements September 30, 2016 (Stated in Canadian Dollars) (Unaudited – Prepared by Management) – Page 2 1. Nature and Operations and Going Concern (continued) As a result of the above noted transactions, the parties who controlled the IP before the Asset Purchase Agreement and the Arrangement continued to control BioMark Diagnostics Inc., including the IP, after the Asset Purchase Agreement and the Arrangement. As a result, no value has been allocated to the 40,000,000 shares issued to BioMark Technologies. On October 15, 2014, Luger, now the wholly-owned subsidiary of BioMark Diagnostics Inc. changed its name to BioMark Cancer Systems Inc. (“BioMark Cancer”). Concurrent with the closing of the Arrangement, the Company placed 40,000,000 of the common shares, representing the shares issued in connection with the Asset Purchase Agreement, into escrow. These shares are subject to a 36-month escrow release period from the completion of the Arrangement with 10% released upon completion of the Arrangement and 15% of such escrowed shares released on the 6, 12, 18, 24, 30 and 36 month anniversaries of the completion of the A